![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
BioDelivery Sciences International, Inc. (NASDAQ: BDSI, BDSIW), a specialty pharmaceutical company, today announced that it has entered into a supply agreement with Aveva Drug Delivery...
? Study Demonstrates BEMA(TM) Fentanyl Has Enhanced Absorption Compared to Market Leader Actiq(R) ? BioDelivery Sciences International, Inc. (NASDAQ: BDSI, BDSIW), a specialty pharmaceutical...
BioDelivery Sciences International, Inc. (NASDAQ:BDSI, BDSIW), a specialty pharmaceutical company, announced today that it has consummated its public offering of 4,400,000 shares of common stock...
BioDelivery Sciences International, Inc. (NASDAQ: BDSI, BDSIW), a specialty pharmaceutical company, announced today that it has priced a public offering of 4,400,000 shares of its common...
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) (NASDAQ:BDSIW), a specialty pharmaceutical company, announced today that it has priced a public offering of 4,400,000 shares of its...
BioDelivery Sciences International, Inc. (NASDAQ: BDSI, BDSIW) announced today that, effective September 15, 2005, Donald Ferguson and Alan Pearce have resigned from the company's board...
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) (NASDAQ:BDSIW) announced today that it has received written notification from the U.S. Food and Drug Administration that its new drug...
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) (NASDAQ:BDSIW) announced today that it has entered into a clinical development and license agreement with Clinical Development Capital, LLC...
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) (NASDAQ:BDSIW) announced today that it has closed an additional $2.5 million secured convertible debt financing from Laurus Master Fund, Ltd...
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) (NASDAQ:BDSIW), announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for Emezine(R), a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions